Adverum Biotechnologies, Inc. (ADVM) NASDAQ

2.43

+0.21(+9.46%)

Updated at June 02 04:00PM

Currency In USD

Valuation

Market Cap92.38M
Enterprise Value123.43M
P/E Ratio-0.41
PEG Ratio0.04
Price/Sales Ratio-19.52
Price/Book Ratio1.93
Enterprise/Revenue-36.45
Enterprise/EBITDA-1.13

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin48.27
Operating Margin46.93

Management Effectiveness

Return On Assets-0.91
Return On Equity-1.23

Income Statement

Revenue1M
Revenue/Share-0.12
Gross Profit-2.65M
EBITDA-127.27M
Net Income-130.93M
Diluted EPS-6.62

Balance Sheet

Total Cash83.08M
Total Cash/Share3.97
Total Debt93.18M
Total Debt/Equity3.53
Current Ratio3.57
Book Value Per Share1.26

Price History

52-Week Change-68.65
52-Week High10.14
52-Week Low1.78
Moving Average 50 Days3.27
Moving Average 200 Days5.31

Statistics

Average Volume325,998
Shares Outstanding20.89M
% Held by Institutions75.61

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateMarch 21, 2024